Skip to content
Stock screener

TNDM Tandem Diabetes Care Inc stock chart & analysis

Conviction 40HealthcareScan · Fri, Nov 6, 2026

Tandem Diabetes Care Inc (TNDM) closed at $16.91 (-6.00%) on Nov 6, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 45, RS Rating 67, -43.0% from its 52-week high, -23.1% year to date. Sector: Healthcare · Surgical & Medical Instruments & Apparatus.

TNDM$16.91-6.00%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
Loading chart…
Tandem Diabetes Care IncSurgical & Medical Instruments & Apparatuswww.tandemdiabetes.com ↗
Price16.91
Change-6.00%
Gap-9.95%
Rel volume2.30×
Avg volume2.57M
Avg $ vol45.69M
SMA 2017.63
SMA 5017.65
SMA 20018.87
Price vs 50-4.19%
Price vs 200-10.38%
MA stackbearish
50/200 cross—
Supertrenddown · 20.24
RSI (14)45
MACD hist-0.02
MACD crossbear · 0d
Stoch %K / %D30 / 50
ADX (14)20
+DI / −DI22 / 27
RSI divergence—
MACD divergence—
ATR %7.13%
ADR %6.08%
52w high29.65
52w low12.26
From 52w high-42.97%
Above 52w low+37.93%
New 52w highNo
SqueezeOff
Bollinger width28.60%
%B0.36
Donchian pos30.42%
Donchian high20.25
Donchian low15.45
AVWAP (52w high)18.65
vs AVWAP high-9.35%
AVWAP (52w low)17.51
vs AVWAP low-3.45%
OBV trendUp
Chaikin MF (20)0.23
Today vs 20d2.30×
Avg vol (14d)2.74M
Avg vol (20d)2.57M
Avg $ vol (20d)45.69M
Market cap1.18B
RS Rating67 / 99
RS 3m (vs SPY)-21.00%
RS 6m (vs SPY)+9.54%
RS line new highNo
Trend template1/8
Technical rank58.9
1 week-11.51%
1 month+7.88%
3 months-25.87%
6 months+9.24%
1 year+15.27%
YTD-23.07%
P/E-5.77
P/B8.74
P/S1.16
P/FCF-39.78
EPS-3.04
Div yield—
ROE-151.54%
ROA-17.66%
Debt/Eq4.77
Current3.21
EV/EBITDA-10.33
Gross margin53.81%
Net margin-20.17%
Rev growth7.93%
EPS growth-113.18%
Price target26.85
Target upside58.78%
Analyst ratingBuy
Institutional125.87%
Ent. value1.75B
Revenue283.69M
Net income-7.08M
Gross profit160.42M
Free cash flow-29.67M
IndustrySurgical & Medical Instruments & Apparatus
ExchangeNasdaq
Shares out—
Employees2.5K
ListedThu, Nov 14, 2013
Free float67.8M
Float %99.0%
Short interest—
Days to cover—
Short volume29.6%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est−$0.10 vs −$0.27
Last surprise+63.0% beat
Setup gradeD
Conviction40 / 100
Pattern quality—
Tech rank58.9 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance19.14
Support14.98
Days since event—
Candle confirm—

Financials as of Wed, Sep 30, 2026 · quarterly.

TNDM technical analysis

Trend

TNDM is in a downtrend: price is below the 50-day, which is below the 200-day moving average. It closed 4.2% below the 50-day ($17.65) and 10.4% below the 200-day ($18.87). ADX(14) at 20 points to a weak trend — more range than direction. It meets 1 of 8 trend-template criteria.

Momentum

RSI(14) is 45, in the bearish half of its range. MACD crossed below its signal line on the latest session. Its RS Rating of 67 puts its weighted 12-month performance ahead of about 67% of the US market.

Volume and volatility

Volume on the latest session ran 2.3× its 20-day average. It trades about $45.7M a day on average. ATR(14) is $1.21, 7.1% of price — its typical daily range. On-balance volume is trending up. Chaikin Money Flow (0.23) shows accumulation.

Key levels

The chart pattern's support is $14.98 and its resistance $19.14. The 52-week range is $12.26 to $29.65; price is 43.0% below the high and 37.9% above the low. The VWAP anchored at the 52-week high is $18.65, above price.

Performance

TNDM returned -11.5% (1 week), +7.9% (1 month), -25.9% (3 months), +9.2% (6 months), +15.3% (1 year), -23.1% (year to date).

About Tandem Diabetes Care Inc

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Surgical & Medical Instruments & Apparatus · Listed 2013 · 2,500 employees

Congress activity

Disclosed STOCK Act trades in TNDM · 5 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2026-09-29
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-03-03
Buy$1K–$15K
Josh Gottheimer
Josh Gottheimer
house · D · NJ · traded 2025-09-22
Buy$1K–$15K
Josh Gottheimer
Josh Gottheimer
house · D · NJ · traded 2025-03-19
Sell$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-03-04
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in TNDM · open-market 1 sell

InsiderSideShares
TWOMEY CHRISTOPHER J
Director · Common Stock · 2026-10-27
Exercise1.7K
TWOMEY CHRISTOPHER J
Director · Common Stock · 2026-10-27
Sell1.7K
TWOMEY CHRISTOPHER J
Director · Stock Option · 2026-10-27
Exercise1.7K
Kyrillos Jean-Claude
EVP & Chief Operating Officer · Common Stock · 2026-10-15
Exercise3.64K
Kyrillos Jean-Claude
EVP & Chief Operating Officer · Common Stock · 2026-10-15
Tax1.93K
Kyrillos Jean-Claude
EVP & Chief Operating Officer · Restricted Stock Unit · 2026-10-15
Exercise3.64K
Gasser Elizabeth Anne
EVP, Chief Strategy Officer · Common Stock · 2026-08-15
Exercise1.1K
Carpenter Rick
EVP & Chief Technology Officer · Common Stock · 2026-08-15
Exercise897
Carpenter Rick
EVP & Chief Technology Officer · Common Stock · 2026-08-15
Tax457
Carpenter Rick
EVP & Chief Technology Officer · Common Stock · 2026-08-15
Exercise1.61K

SEC filings

EDGAR filings in TNDM · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.